Cancer is a disease that undergoes selective pressure to evolve during its progression,
becoming increasingly heterogeneous. Tumoral heterogeneity can dictate therapeutic …

Prostate cancer (PCa) is one of the most prevalent malignancies in males worldwide.
Increasing research attention has focused on the PCa microenvironment, which plays a …

Artificial Intelligence (AI) has emerged as a transformative tool in predicting metastasis risk
and survival outcomes in cancer care. Traditional methods for assessing cancer progression …

Esophageal squamous cell carcinoma (ESCC) presents significant clinical and therapeutic
challenges due to its aggressive nature and generally poor prognosis. We initiated a Phase …

Abstract Fructose 1, 6-diphosphatase 1 (FBP1) is an enzyme involved in gluconeogenesis
and glycolysis inhibition. Dendritic cells (DCs) are antigen-presenting cells, and antigens …

Colorectal cancer (CRC) is the third most common cancer and the second leading cause of
cancer-related deaths worldwide. Dendritic cells (DCs) constitute a heterogeneous group of …

Head and neck cancer (HNC) is a prevalent malignant tumor that is aggressive and
frequently resistant to treatment. Immunotherapy, a new approach for treating head and neck …